InVitria Announces Launch of Recombinant Albumin for Diagnostics

InVitria's Recombinant Albumin-DX eliminates safety concerns, stabilizes sensitive biomarkers and enhances diagnostic performance by improving specificity.

Fort Collins, CO (PRWEB) April 2, 2009 -- Addressing significant product safety and consistency issues in the human diagnostics market, InVitria has announced the commercial launch of two protease-free recombinant albumin products. InVitria's Recombinant Albumin-DX and Recombinant Albumin-DX (Lipid-Free) perform better in diagnostics applications than both bovine serum albumin (BSA) and plasma-derived human serum albumin (pHSA).

The advantages of Recombinant Albumin-DX include:

• Reduce non-specific binding and improve specificity;

• Improved consistency due to recombinant manufacturing;

• Improved stabilization of sensitive proteins and biomarkers; and

• Reduce occupational safety risk and regulatory burden of handling human or animal blood products.

Customer testing has shown that Recombinant Albumin-DX (Lipid-Free) increased biomarker activity to levels twice as high as the current commercial alternative. In addition, stability over time was significantly improved with Recombinant Albumin-DX (Lipid-Free). Tests have also shown the bioequivalence of the Recombinant Albumin-DX to native human serum albumin (HSA).

"InVitria is committed to developing high performance, regulatory friendly products for the diagnostics market and our Recombinant Albumin-DX and DX Lipid-Free products deliver on this promise," said the company's President and CEO Scott Deeter. "Recombinant Album-DX and DX Lipid-Free provide the specificity, stability and consistency that diagnostic customers seek."

To receive a Recombinant Albumin-DX or DX Lipid-Free product materials packet, please contact InVitria's customer service specialists at 1-800-916-8311 or by e-mail at info@InVitria.com.

About InVitria

InVitria develops, manufactures and markets a portfolio of cell culture and diagnostic reagents. These products are used in cell culture, biopharmaceutical formulation, stem cell & regenerative medicine, medical devices and diagnostics.

Learn more about InVitria's products at Diagnostics (http://www.invitria.com)

###


Contact Information
Erik Vogel
InVitria
http://www.invitria.com
970-219-3580

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy